SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP AFP ASSAY KIT, TEST,ALPHA-FETOPROTEIN FOR TESTICULAR CANCER; KIT, TEST, ALPHA-FETOPROTEIN
|
Back to Search Results |
|
Model Number N/A |
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 08/31/2018 |
Event Type
malfunction
|
Manufacturer Narrative
|
The cause for the falsely elevated advia centaur xp alpha-fetoprotein (afp) patient results is unknown.
The customer's assay calibration and quality controls (qc) were acceptable.
The customer informed siemens that initial afp concentrations were not above the assay measurement range.
For example: the sample from (b)(6) had an initial afp result of 7.
5 ug/l, when pre-diluted with negative serum pool and tested the next day, the results were 1.
7 ug/l (1:10), 14.
5 ug/l (1:20), 49.
8 (1:200) and eventually yielding a result of > 1000 ug/l.
Siemens is investigating the event.
The instruction for use (ifu) under the interpretation of results section states the following: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.
" mdr 1219913-2018-00309 was filed for an elevated afp result on the same patient on a different day.
|
|
Event Description
|
Falsely elevated advia centaur xp alpha-fetoprotein (afp) results were observed on a patient sample and questioned by the physician.
The patient was transferred to another hospital for a liver transplantation in (b)(6) 2018, however the afp measured at this hospital was normal.
The patient was discharged with no abnormality detected.
There are no reports of adverse health consequences due to the discordant advia centaur xp afp results.
Mdr 1219913-2018-00309 was filed for an elevated afp result on the same patient on a different day.
|
|
Search Alerts/Recalls
|
|
|